12-123933342-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001372106.1(DNAH10):​c.13308C>T​(p.Ser4436Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.301 in 1,572,818 control chromosomes in the GnomAD database, including 72,802 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7065 hom., cov: 33)
Exomes 𝑓: 0.30 ( 65737 hom. )

Consequence

DNAH10
NM_001372106.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.63

Publications

21 publications found
Variant links:
Genes affected
DNAH10 (HGNC:2941): (dynein axonemal heavy chain 10) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. The axonemal dyneins, found in cilia and flagella, are components of the outer and inner dynein arms attached to the peripheral microtubule doublets. DNAH10 is an inner arm dynein heavy chain (Maiti et al., 2000 [PubMed 11175280]).[supplied by OMIM, Mar 2008]
DNAH10OS (HGNC:37121): (dynein axonemal heavy chain 10 opposite strand)
CCDC92 (HGNC:29563): (coiled-coil domain containing 92) Enables identical protein binding activity. Located in centriole; centrosome; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 12-123933342-C-T is Benign according to our data. Variant chr12-123933342-C-T is described in ClinVar as Benign. ClinVar VariationId is 402625.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.63 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.316 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH10NM_001372106.1 linkc.13308C>T p.Ser4436Ser synonymous_variant Exon 77 of 79 ENST00000673944.1 NP_001359035.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH10ENST00000673944.1 linkc.13308C>T p.Ser4436Ser synonymous_variant Exon 77 of 79 NM_001372106.1 ENSP00000501095.1

Frequencies

GnomAD3 genomes
AF:
0.303
AC:
46013
AN:
151996
Hom.:
7062
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.321
Gnomad AMI
AF:
0.371
Gnomad AMR
AF:
0.284
Gnomad ASJ
AF:
0.348
Gnomad EAS
AF:
0.127
Gnomad SAS
AF:
0.215
Gnomad FIN
AF:
0.270
Gnomad MID
AF:
0.320
Gnomad NFE
AF:
0.317
Gnomad OTH
AF:
0.325
GnomAD2 exomes
AF:
0.276
AC:
60043
AN:
217258
AF XY:
0.277
show subpopulations
Gnomad AFR exome
AF:
0.314
Gnomad AMR exome
AF:
0.237
Gnomad ASJ exome
AF:
0.350
Gnomad EAS exome
AF:
0.114
Gnomad FIN exome
AF:
0.269
Gnomad NFE exome
AF:
0.321
Gnomad OTH exome
AF:
0.301
GnomAD4 exome
AF:
0.300
AC:
426778
AN:
1420704
Hom.:
65737
Cov.:
34
AF XY:
0.299
AC XY:
210179
AN XY:
703514
show subpopulations
African (AFR)
AF:
0.319
AC:
10157
AN:
31812
American (AMR)
AF:
0.245
AC:
10090
AN:
41154
Ashkenazi Jewish (ASJ)
AF:
0.348
AC:
8717
AN:
25024
East Asian (EAS)
AF:
0.137
AC:
5109
AN:
37362
South Asian (SAS)
AF:
0.210
AC:
17199
AN:
81796
European-Finnish (FIN)
AF:
0.285
AC:
14710
AN:
51676
Middle Eastern (MID)
AF:
0.347
AC:
1411
AN:
4068
European-Non Finnish (NFE)
AF:
0.314
AC:
341709
AN:
1089428
Other (OTH)
AF:
0.303
AC:
17676
AN:
58384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
14807
29614
44421
59228
74035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11172
22344
33516
44688
55860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.303
AC:
46042
AN:
152114
Hom.:
7065
Cov.:
33
AF XY:
0.297
AC XY:
22095
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.321
AC:
13302
AN:
41460
American (AMR)
AF:
0.284
AC:
4341
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.348
AC:
1209
AN:
3470
East Asian (EAS)
AF:
0.127
AC:
660
AN:
5180
South Asian (SAS)
AF:
0.215
AC:
1035
AN:
4824
European-Finnish (FIN)
AF:
0.270
AC:
2857
AN:
10590
Middle Eastern (MID)
AF:
0.337
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
0.317
AC:
21520
AN:
67976
Other (OTH)
AF:
0.322
AC:
681
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1653
3306
4958
6611
8264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.313
Hom.:
3978
Bravo
AF:
0.307
Asia WGS
AF:
0.208
AC:
725
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

DNAH10-related disorder Benign:1
Oct 31, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
0.013
DANN
Benign
0.77
PhyloP100
-2.6
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4930721; hg19: chr12-124417889; COSMIC: COSV53020069; COSMIC: COSV53020069; API